Danimer Scientific Inc. made misleading claims about its biodegradable product and production figures, causing its investors significant damage, according to a Friday complaint in federal district court in New York.
Darryl Keith Rosencrants, an investor who acquired Danimer securities, alleged the company’s executives knew they were concealing information from the public. They artificially inflated the company’s value with false statements, according to a class action in the U.S. District Court for the Eastern District of New York.
The company, formerly Live Oak Acquisition Corp., combined with Meredian Holdings Group Inc. in December to become Danimer Scientific. The company sells polyhydroxyalkanoates, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.